Related Experiment Videos
[Pergolide: a useful agonist for the treatment of Parkinson disease]
1Fédération de Neurologie, INSERM U289, Hôpital Pitié-Salpêtrière, 47 Bd de L'Hôpital, 75651 Paris.
Revue Neurologique
|December 19, 2002
Abstract:
The efficiency of pergolide has been confirmed by the study of a group 29 parkinsonian patients. They were relatively young, and the duration of evolution of their Parkinson's disease was more then ten years, with levodopa-induced dyskinesia and fluctuations. In this group of patients with most serious motor disability, it has been possible to improve dyskinesia and fluctuations with a relatively important dosage of pergolide and without increase of levodopa dosage.